HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabeth M Haberl Selected Research

syntrophin alpha1

1/2020Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver.
5/2018Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
1/2018Alpha-syntrophin deficient mice are protected from adipocyte hypertrophy and ectopic triglyceride deposition in obesity.
10/2017The adaptor protein alpha-syntrophin is reduced in human non-alcoholic steatohepatitis but is unchanged in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabeth M Haberl Research Topics

Disease

8Neoplasms (Cancer)
10/2021 - 04/2017
7Inflammation (Inflammations)
05/2021 - 01/2017
6Hepatocellular Carcinoma (Hepatoma)
10/2021 - 04/2017
6Alcoholic Fatty Liver
12/2020 - 01/2017
5Liver Cirrhosis (Hepatic Cirrhosis)
08/2022 - 06/2017
5Fibrosis (Cirrhosis)
05/2021 - 01/2017
5Non-alcoholic Fatty Liver Disease
12/2020 - 01/2017
3Obesity
03/2019 - 01/2018
2Hepatitis B
05/2021 - 10/2020
2Hypertrophy
01/2019 - 01/2018
2Type 2 Diabetes Mellitus (MODY)
10/2017 - 01/2017
1Infections
05/2021
1Carcinogenesis
12/2020
1Neoplasm Metastasis (Metastasis)
10/2020
1Liver Neoplasms (Liver Cancer)
12/2019
1Insulin Resistance
09/2019
1Weight Loss (Weight Reduction)
01/2019
1Fatty Liver
01/2018
1Body Weight (Weight, Body)
01/2018
1Liver Diseases (Liver Disease)
10/2017
1Hepatitis
06/2017
1Portal Hypertension
06/2017

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
08/2022 - 06/2017
8LipidsIBA
10/2021 - 01/2018
6Triglycerides (Triacylglycerol)IBA
10/2021 - 10/2017
5Choline (Choline Chloride)IBA
12/2020 - 01/2018
5Methionine (L-Methionine)FDA Link
12/2020 - 01/2018
5Messenger RNA (mRNA)IBA
10/2020 - 01/2017
4CeramidesIBA
10/2021 - 09/2019
4CholesterolIBA
10/2021 - 10/2017
4syntrophin alpha1IBA
01/2020 - 10/2017
3Diethylnitrosamine (N-Nitrosodiethylamine)IBA
10/2021 - 01/2018
2Phospholipids (Phosphatides)FDA LinkGeneric
05/2021 - 12/2020
2DiglyceridesIBA
05/2021 - 12/2019
2Chemokine ReceptorsIBA
10/2020 - 01/2017
2Protein Isoforms (Isoforms)IBA
12/2019 - 03/2019
2Biological ProductsIBA
03/2019 - 01/2018
2AdiponectinIBA
02/2018 - 06/2017
2LeptinIBA
01/2018 - 06/2017
2AdipokinesIBA
01/2018 - 06/2017
1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA
10/2021
1SphingomyelinsIBA
10/2021
1Lipase (Acid Lipase)FDA Link
10/2021
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
10/2021
1Tumor Suppressor Protein p53IBA
10/2021
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2021
1EnzymesIBA
12/2020
1RetinoidsIBA
10/2020
1tazarotene (Tazorac)FDA Link
10/2020
1PTX3 proteinIBA
05/2020
1Galectin 3 (LGALS3)IBA
01/2020
1syntrophinIBA
01/2019
1fibroblast growth factor 21IBA
02/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Extracellular Matrix ProteinsIBA
06/2017
1TubulinIBA
04/2017
1LipopolysaccharidesIBA
01/2017
1CC ChemokinesIBA
01/2017

Therapy/Procedure

1Therapeutics
10/2021
1Bariatric Surgery
01/2019
1Transjugular Intrahepatic Portasystemic Shunt
06/2017